Finanzwire Finanzwire
Basculer en Français
10465 Companies
220161 Keywords
149466 Articles
116390 Press releases
Headlines Articles Press releases Americord Remove
  1. Home
  2. Companies
  3. Americord
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/23/2024 at 16:30, 2 years 3 months ago

    Americord makes breakthrough in treating Motor Neuron Disease with cord blood stem cells

    Americord Stem Cells Cord Blood Motor Neuron Disease Treatment
  • PRESS RELEASE

    published on 02/23/2024 at 16:30, 2 years 3 months ago

    Americord Releases Cord Blood Stem Cells for Treatment of Motor Neuron Disease

    Americord releases cord blood stem cells for the treatment of motor neuron disease in India, highlighting the therapeutic potential of stem cells in healthcare
    Healthcare Americord Motor Neuron Disease Treatment Cord Blood Stem Cells
    Logo of Americord
  • PRESS RELEASE

    published on 12/06/2023 at 15:00, 2 years 5 months ago

    Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey

    Americord, a leader in the biobanking industry, has relocated its laboratory from New York City to a state-of-the-art facility in Somerset, New Jersey, marking a milestone in advancing research, product quality, and growth opportunities
    Americord Biobanking Laboratory Relocation Research Somerset New Jersey
    Logo of Americord
Accesswire
  • Published on 05/28/2026 at 13:30, 39 minutes ago

    ROK Resources Files Financial Results and Management Discussion & Analysis for First Quarter of 2026

  • Published on 05/28/2026 at 13:30, 39 minutes ago

    Nextech3D.ai Announces Appointment of VP of Sales and CFO Share Issuance

  • Published on 05/28/2026 at 13:30, 39 minutes ago

    Algo Grande Finalizes Phase II Drill Targets Following Completion of High-Definition Surveys

  • Published on 05/28/2026 at 13:00, 1 hour 9 minutes ago

    Galway Metals' District-Scale Geophysics Defines High-Priority Target Corridor Between Clarence Stream's Two Largest Gold Deposits

  • Published on 05/28/2026 at 13:00, 1 hour 9 minutes ago

    Aztec Minerals Increases Tombstone Drilling Program by 3,500 Meters

View all ACCESSWIRE
EQS Group
  • Published on 05/28/2026 at 13:43, 26 minutes ago

    Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Research GmbH): BUY

  • Published on 05/28/2026 at 13:40, 28 minutes ago

    STRADVISION and aiMotive Combine Perception-Driven Scenario Understanding and Scalable Simulation for ADAS Validation

  • Published on 05/28/2026 at 13:15, 54 minutes ago

    Global Filmmakers Are Leveraging Kling AI to Push the Boundaries of Storytelling, Cannes Panel Presents

  • Published on 05/28/2026 at 13:12, 56 minutes ago

    Share Buyback for the Employee Participation Program

  • Published on 05/28/2026 at 12:56, 1 hour 12 minutes ago

    20 years of KION – connecting the heritage with the future at the Annual General Meeting 2026

View all EQS
Les Echos
  • Published on 05/28/2026 at 10:30, 3 hours 39 minutes ago

    Recticel Group included in Top 100 Financial Times list of Europe’s Climate Leaders

  • Published on 05/28/2026 at 08:45, 5 hours 24 minutes ago

    Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski

  • Published on 05/27/2026 at 23:00, 15 hours 9 minutes ago

    BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE

  • Published on 05/27/2026 at 20:28, 17 hours 40 minutes ago

    Combined Shareholders’ Meeting of May 27, 2026

  • Published on 05/27/2026 at 17:45, 20 hours 24 minutes ago

    Imerys-05-2026-information-share-capital-and-voting-rights-as-of-30-April-2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy